When we propose a new approach to solve a clinical problem, we often determine its effectiveness by how safe it is. In the field of healthcare, this means peer-reviewed research that objectively analyses its accuracy, reliability and reproducibility. As we gather robust evidence, we will seek to certify our proprietary triage tool as a Class 2A Medical Device through the MHRA.
As we design our pilot study, we focus on measuring quantitative outcomes that translate the clinical benefits into tangible results. These include:
- Patient Activation Measure 13
- Technology Acceptance Model
- Cashable Savings for Public Health Systems